Release Date: 13/03/20 09:28 Summary: Announcement under ASX Operating Rule 10A.4.3 Price Sensitive: No Download Document 94.53KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%